Currently, the available laboratory data clearly indicate that by taking advantage of PERK’s dual role—initially adaptive but cytotoxic in the event of prolonged stress—targeting this kinase makes it possible to achieve better cytotoxic effects in vitro on cancer cells in culture and to induce a more effective antitumor response in vivo in various animal models of cancer. This evidence concerns the gene EIF2AK3 and cancer.